BCL2 and colorectal carcinoma: Thus, it was resolved that HNPMI could potentially regulate the CRC disease progression, especially in HT‐29 cells, through the EGFR‐mediated BCL‐2/BAX mediated cascade, thus regulating apoptosis by the intrinsic apoptotic pathway.